Sumitomo Mitsui Trust Group
RVMD icon

Sumitomo Mitsui Trust Group’s Revolution Medicines RVMD Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$77.7M Buy
378,702
+72,402
+24% +$14.4M 0.04% 341
2026
Q2 		$57.4M Buy
306,300
+35,328
+13% +$5.16M 0.03% 422
2026
Q1 		$26.4M Buy
270,972
+265,474
+4,829% +$26.8M 0.02% 584
2025
Q4 		$438K Buy
+5,498
New +$361K ﹤0.01% 964

Other funds holding RVMD

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Chicago Capital
Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Loftus Peak
Loftus Peak Sydney, Australia $781M AUM
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Sumitomo Mitsui Trust Group's RVMD Position: Q3 2026 in Review

Sumitomo Mitsui Trust Group increased its Revolution Medicines (RVMD) stake by 24% in Q3 2026, buying an estimated $14.4M and bringing the position to 378,702 shares worth $77.7M. The position accounts for 0.04% of the portfolio, ranked #341.

Sumitomo Mitsui Trust Group first reported a position in RVMD in Q4 2025 and has held it in 4 quarters since. 212 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Sumitomo Mitsui Trust Group held 378,702 shares of Revolution Medicines worth $77.7M as of Q3 2026.
  • Sumitomo Mitsui Trust Group bought 72,402 Revolution Medicines shares in Q3 2026, an estimated $14.4M.
  • Revolution Medicines made up 0.04% of Sumitomo Mitsui Trust Group's portfolio in Q3 2026, its #341 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Revolution Medicines in Q4 2025 and has held it in 4 quarters since.
  • 212 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q3 2026, filed 29 Oct 2026.